<<

Human Alveolar Macrophage Cytophilic -mediated of A-Positive Staphylococci

HENRI A. VERBRUGH, JOHN R. HOIDAL, BACH-YEN T. NGUYEN, JAN VERHOEF, PAUL G. QUIE, and PHILLIP K. PETERSON, Departments of Medicine and Pediatrics, University of Minnesota School of Medicine, Minneapolis, Minnesota 55455; Laboratory for Microbiology, University of Utrecht School of Medicine, Utrecht 3511 GG, The Netherlands

A B S T R A C T Human alveolar macrophages (AM) body to human IgG, but not with IgA- or IgM-specific have recently been reported to ingest and kill a strain conjugates. No such surface-immunoglobulins were of (502A) in the absence of detected on PMN, and MN were only weakly positive . To further investigate the mechanism of non- for surface IgG. Pretreatment of AM with F(ab')2 frag- opsonic recognition, we studied phagocytosis of 23 ments specific for human IgG (anti-Fc) inhibited sub- clinical and laboratory strains of S. aureus and Staph- sequent phagocytosis of protein A-positive staphylo- ylococcus epidermidis by AM, and by blood poly- cocci. There was no evidence that the AM surface IgG morphonuclear leukocytes (PMN) and monocytes was aggregated or immunecomplexed. (MN). In the absence of opsonins, AM phagocytized From these studies we conclude that human AM 18 protein A-positive but not 5 protein A-negative possess cytophilic IgG , which can function strains of staphylococci, and the efficiency of phago- as receptors for phagocytosis of protein A-positive cytosis directly correlated with the amount of protein staphylococci. A present in the bacterial cell wall (r = 0.86, P < 0.001). Furthermore, AM rosetted around protein INTRODUCTION A-coated Sepharose beads, but not around beads with- out protein A. In contrast, PMN did not phagocytize As part of an endeavor to elucidate the mechanisms nonopsonized staphylococci, and did not rosette around underlying the process of phagocytosis, our laborato- either type of Sepharose. MN phagocytized protein A- ries have studied the opsonic recognition of several positive staphylococci, but much less efficiently than bacterial species, including Staphylococcus aureus, by AM, and showed some rosetting around protein A- human peripheral blood , i.e., the poly- coated Sepharose. morphonuclear leukocytes (PMN)l and monocytes The nature of the AM receptor for protein A-positive (MN) (1-3). Results of these studies and those of other staphylococci was studied. The surface of AM was investigators (4-6) have indicated that, although the positively stained with fluorescein-conjugated anti- requirement for opsonic factors may differ among strains of staphylococci, significant phagocytosis and Portions of this work were presented at the Association of killing of these bacteria will not occur in the complete American Physicians, American Society for Clinical Inves- absence of serum opsonins. Major staphylococcal op- tigation, and American Federation for Clinical Research sonins are a fragment of the third component of com- National Meeting, San Francisco, Calif., 27 April 1981, and appeared in abstract form in 1981. Clin. Res. 29: 398a. plement (C3b) and IgG class of antibodies. The pep- Dr. Hoidal is the recipient of a Young Investigator Award tidoglycan component of the staphylococcal cell wall HL 24653-01 of the National Heart, Lung, and Blood In- stitute, Dr. Quie is the American Legion Heart Research I Abbreviations used in this paper: agg-IgG, heat-aggre- Professor of Pediatrics. Address correspondence to Dr. Henri gated human IgG; AM, alveolar macrophages; FITC, fluo- A. Verbrugh, Department of Medicine, University of Min- rescein isothiocyanate; GHBSS, HBSS containing 0.1% ge- nesota School of Medicine, Minneapolis, Minn. 55455. latin; HBSS, Hanks' balanced salt solution; MN, monocytes; Received for publication 20 April 1981 and in revised PBS, phosphate-buffered saline; PMN, polymorphonuclear form 17 September 1981. leukocytes; SRBC, sheep erythrocytes.

J. Clin. Invest. © The American Society for Clinical Investigation, Inc. - 0021-9738/82/01/0063/12 $1.00 63 Volume 69 January 1982 63-74 has been proposed to be the key bacterial structure tions varied between 25 and 45% with the remainder of the that interacts with these opsonins (7, 8). cell population being primarily lymphocytes. The suspen- sions were adjusted to contain 5 X 106 MN/ml in GHBSS. In an attempt to define the opsonic requirements for MN viability was always >95%. In some experiments MN bacterial phagocytosis by extravascular phagocytes, we were further purified using a slight modification of the have recently studied the interactions between staph- method of Ackerman and Douglas (9, 14) using microex- ylococci and human alveolar macrophages (AM) (9, udate-coated surfaces. MN purity in these suspensions was always >95% and viability was 290%. 10). These studies led to the surprising observation that AM were obtained from normal donors by subsegmental AM were able to ingest and kill a strain of S. aureus saline lavage of the lingula of the left lung, or the middle (502A) in the absence of opsonins. The goal of the lobe of the right lung, as previously described (15). AM were present investigation was to determine the basis of this obtained from smokers and nonsmokers. AM in the recovered phenomenon. A total of 23 selected staphylococcal lavage fluid were washed three times with GHBSS and re- suspended at a concentration of 5 X 106 AM/ml GHBSS. strains with major differences in cell wall composition Purity of AM suspensions was >85% (remaining cells were were studied. We have found that protein A is the cell primarily lymphocytes) and viability exceeded 94% in all wall component of staphylococci that is recognized by cases. The cell-free lavage fluids were routinely concentrated AM, and discovered that human AM possess cytophilic 150-fold by positive pressure ultrafiltration through a PM 10 membrane (Amicon Corp., Scientific Sys. Div., Lexington, IgG antibodies. Nonopsonic phagocytosis appears to Mass.) and stored at -70°C until use. result from the binding of protein A to the Fc portion To study tissue macrophages from another site of the hu- of the IgG molecules on the surface of AM. man body, about 2.5 liters of peritoneal dialysate was ob- tained from four clinically stable patients on chronic peri- toneal dialysis for renal failure. None of the patients had a METHODS history of previous peritonitis. Peritoneal cells were prepared Bacterial strains and cultural conditions. Previously de- in a manner similar to that for AM. Between 20 and 70 scribed laboratory strains of S. aureus were 502A, Ev, Cowan X 106 cells were obtained and the final suspensions (in I, EMS (an induced protein A-deficient mutant of Cowan GHBSS) contained a mean (range) percent of 70 (64-83)% I provided by A. Forsgren, Malmo University, Malmo, Swe- of macrophages, 24 (14-30)% lymphocytes, and 6 (3-10)% den), Wood 46 (a noninduced protein A-poor strain), H PMN. Viability exceeded 95% in each case. HSmR (a spontaneous streptomycin-resistant mutant of For some experiments AM were also obtained from 2-2.5- strain H), 52A5 (a teichoic acid-deficient mutant of HSmR, kg wild rabbits, 275-325-g Sprague-Dawley rats, and from both provided by J. T. Park, Tufts University, Boston, Mass.), 100-g Syrian golden hamsters by a standard lung lavage tech- and the encapsulated M and Smith strains with their re- nique using sterile saline (16). Each of the suspensions con- spective nonencapsulated variant strains (Smith compact and tained 295% AM, and AM viability was .90%. M variant), kindly provided by A. Melly, Vanderbilt Uni- Opsonins and opsonization procedure. Serum from 10 versity, Nashville, Tenn. (1, 7, 8, 11). Another related pair healthy donors was pooled and stored in 1-ml portions at of S. aureus strains, one of which was coagulase- and clump- -70°C. Just before use, serum was thawed and diluted to ing factor-negative, was kindly donated by C. P. A. Van 10% in GHBSS. 100 ,ul of the bacterial suspension (-5 X 107 Boven (University of Limburg, Maastricht, the Netherlands). microorganisms) was mixed with 0.9 ml of 10% serum or In addition, six strains of S. aureus and three strains of Staph- with 0.9 ml GHBSS, and incubated for 30 min at 370C. The ylococcus epidermidis were fresh clinical isolates from the suspension was then designated opsonized (10% serum) or blood of bacteremic patients. ON2 (serotype nonopsonized (GHBSS) bacteria, and held at 4°C until use. 022:H16) is a serum resistant strain provided by B. Bjorksten Heat-aggregated human IgG (agg-IgG, 10 mg/ml) was a gift (University of Umea, Umea, Sweden) (12). All strains were of Dr. F. G. Cosio (Department of Pediatrics, University of maintained on blood agar plates at 4°C. Minnesota School of Medicine, Minneapolis). For each experiment bacteria were grown in Mueller Hin- Phagocytosis assay. The uptake of opsonized and non- ton broth (Difco Laboratories, Detroit, Mich.) in a 37°C opsonized bacteria by phagocytes was determined using ra- shaking incubator for 18 h, washed three times with phos- diolabeled bacteria in an assay that has been described in phate-buffered saline (PBS) pH 7.4, and resuspended in PBS detail previously (2, 8). Briefly, 100 ul of the opsonized or to a concentration of 5 X 10' microorganisms/ml. For phago- nonopsonized bacterial suspension was mixed with 100 ,l of cytosis studies, the bacteria were radiolabeled by inoculating either PMN, MN, or AM in polypropylene vials (Bio-vials, into 10 ml Mueller Hinton broth containing 20 MCi of [2,8- Beckman Instruments Inc., Fullerton, Calif.), and phago- 3H]adenine (sp act 34 Ci/mM, ICN Corporation, Irving, cytosis was allowed to proceed for indicated times in a 37°C Calif.), as previously described (7). shaking incubator. The final bacteria to ratio was Isolation of phagocytic cells. PMN and MN were re- -10:1. Phagocytosis was interrupted by adding 3-ml ice- covered from venous donor blood drawn into heparinized cold PBS to the mixture. Nonphagocyte-associated bacteria syringes (10 U heparin/ml blood) using a method modified were removed by three cycles of differential centrifugation from Boyum (13) as described previously (7). The final PMN (5 min, 160g, 4°C) and the phagocyte-associated radioac- pellets were resuspended to a concentration of 5 X 106 PMN/ tivity in the final pellets was determined by liquid scintil- ml in Hanks' balanced salt solution (HBSS) containing 0.1% lation counting as described (9). Phagocytosis was expressed gelatin (GHBSS). Purity was evaluated by Wright's stained as a percent uptake of total added radioactivity, determined smears and viability by trypan blue exclusion; both in a separate vial (2). exceeded 95%. Measurement of superoxide anion (O°) production. Re- The MN containing mononuclear cell layer was washed lease of O2 by AM was measured by the cytochrome c re- three times with GHBSS, and total and differential counts duction method (17). 1 ml reaction mixtures containing 5 were performed. The percentage of MN in these prepara- X 10' AM with or without bacteria (2.5 X 108) were incu-

64 Verbrugh, Hoidal, Nguyen, Verhoef, Quie, and Peterson bated with shaking for 20 min at 37°C in the presence of cytes around Sepharose CL-4B without covalently linked horse heart ferricytochrome c (Sigma Chemical Co., St. protein A was likewise studied. Louis, Mo.). Parallel identical mixtures were incubated con- Surface immunoglobulin assay. Immunofluorescent taining in addition 50 ug/ml superoxide dismutase (2,000 staining of PMN, MN, and AM for the presence of surface U/ml, Truett Laboratories, Dallas, Tex.). Identical samples immunoglobulins was performed with the kind assistance of with and without superoxide dismutase were also run at 4°C. K. J. Gajl-Peczalska (Cell-Marker Laboratory, University of After incubation, the reaction mixtures were held in an ice- Minnesota School of Medicine, Minneapolis) according to bath, and centrifuged (10 min, 800 g, 4°C). The absorbance previously described methods (19). Briefly, 1 X 106 cells in at 550 nm of each supernatant was measured in a Beckman PBS containing 2% fetal calf serum and 15 mg/100 ml so- 24 spectrophotometer (Beckman Instruments, Inc.) using the dium azide were mixed with 2 vol of fluorescein isothiocy- 4°C incubation mixtures as blanks. Results are expressed as anate-conjugated (FITC) antibodies, polyvalent or mono- nanomoles of superoxide dismutase inhibitable cytochrome specific for the major heavy-chain classes (a, y,,u). FITC- c reduced per 20 min/5 X 10' AM (17). protein A (Pharmacia Fine Chemicals), diluted 1:20, was Measurement of hexose monophosphate shunt activity. also used. The cells were incubated at 4°C for 45 min and The hexose monophosphate shunt activity of AM was as- then washed three times with the same PBS by centrifugation sessed by the conversion of [1-'4Cjglucose to 14CO2, as pre- (5 min at 1,200 rpm). After decanting, the final pellets were viously described (17). Incubation mixtures contained 5 gently resuspended in the fluid remaining in the tubes, and X 10' AM, bacteria (2.5 X 108), 1.0 MM glucose, and 1.0 yCi samples were sealed under cover slips on clean microscope as [1-'4C]glucose (New England Nuclear, Boston, Mass.). slides. Slides were examined on a Zeiss universal photomi- 14CO2 produced during a 20-min incubation in a 37°C shak- croscope equipped with epifluorescence, phase contrast, and ing water-bath was trapped on filter paper saturated with photography systems. 20% sodium hydroxide. Filter papers were allowed to dry Trypsinization of staphylococci. To remove cell surface at room temperature, and radioactivity in the filter papers , staphylococci (5 X 108 ml in HBSS) were incubated was determined by liquid scintillation counting. Results are with 1 mg/ml HBSS of trypsin (type IX, Sigma Chemical expressed as counts per minute per 20 min/5 X 106 AM (16). Co.) for 30 min at 37°C. After incubation, trypsin activity Parallel tubes contained AM without bacteria ("resting" was neutralized by adding a twofold excess of chicken egg AM), bacteria without AM, and GHBSS alone. white trypsin inhibitor (type 111-0, Sigma Chemical Co.), Quantitation of staphylococcal protein A. The amount and washing the bacteria three times with PBS. The final of protein A present on the surface of intact staphylococci bacterial pellet was resuspended with GHBSS to 5 X 108 bac- was measured using the ability of protein A to agglutinate teria/ml. Control bacteria were incubated with HBSS alone -coated erythrocytes (18). A 1% suspension of sheep and treated likewise. erythrocytes (SRBC) was sensitized with a subagglutinating Pretreatment of AM. In some experiments AM (5 X 106/ dose of rabbit IgG antibody to SRBC (N. L. Cappel Labo- ml in HBSS) were incubated for indicated times at 37°C ratories, Inc., Cochranville, Pa.), washed, and 0.1 ml was with one of the following substances: trypsin (type IX, Sigma aliquoted into V-shaped wells of Cooke microtiter trays Chemical Co.), pronase (type VI, Sigma Chemical Co.), (Dynatech Laboratories, Inc., Alexandria, Va.). 100 ul of neuraminidase (type VIII, Sigma Chemical Co.), purified serial twofold dilutions of the bacterial suspension (1 X 10' protein A (Pharmacia Fine Chemicals), or goat F(ab')2 frag- microorganisms/ml) were added to the wells, thoroughly ments specific for the Fc portion of human IgG (heavy chain mixed with the sensitized SRBC, and incubated for 4 h at specific) (N. L. Cappell Laboratories Inc., Lot 14075). AM 37°C. The hemagglutinating titer of each strain was read were likewise treated with 1 mg/ml papain (type III, Sigma as the highest dilution of the bacterial suspension that gave Chemical Co.) in the presence of 0.01 M cystein and 2 mM visible agglutination. Bacterial hemagglutinating titers were EDTA. After incubation, AM were washed twice with cold compared to the hemagglutinating titer of a simultaneously GHBSS, resuspended to the original concentration, and im- run solution containing 5 gg/ml of purified protein A (Phar- mediately used. Excess trypsin inhibitor (type III-0, Sigma macia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, Chemical Co.) or bovine serum albumin (Reheis Co., Inc., N. J.). This allowed for the amount of protein of each strain Phoenix, Ariz.) were added after incubation of AM with to be expressed as picograms of protein A/I X 106 cocci. trypsin and pronase, respectively. Control AM were incu- The results are based on duplicate tests performed on 3 sep- bated with HBSS alone and likewise treated. arate d; day-to-day variation in hemagglutinating titers Pretreatment of PMN. For some studies PMN (5 X 106/ never exceeded one twofold dilution step. Appropriate con- ml) were incubated with 1 mg agg-IgG/ml or with concen- trols were bacteria incubated with nonsensitized SRBC, and trated lung lavage fluid for 2.5 h at 4°C. After incubation sensitized SRBC incubated with PBS alone. The suspensions these cells were washed twice with cold GHBSS and used were in PBS. immediately. "Sepharose-rosette" assay. The ability of PMN, MN, and Statistical analysis. Standard error was used as an esti- AM to form rosettes around beads of Sepharose® CL-4B with mate of variance and statistical significance was assessed covalently linked protein A residues (Pharmacia Fine Chem- using the Student's t test for paired observations. The Pear- icals) was determined by incubating 0.5 ml of the phagocyte son product-moment correlation coefficient (r) was used to suspension with 0.1 ml beads (packed volume) for 30 min measure linear correlations between two variables (20). at 37°C with intermittent agitation. The preswollen Se- pharose was allowed to equilibrate with GHBSS before use. RESULTS After incubation, an equal volume of methylene blue (0.1%) was added and samples were sealed under cover slips on Phagocytosis of clinical isolates of S. aureus. To clean microscope slides. Rosetting of phagocytic cells around extend our previous observation on the nonopsonic Sepharose beads was evaluated on a Zeiss photomicroscope (Carl Zeiss, Inc., Oberkocten, West Germany), and the per- uptake of a laboratory strain of S. aureus by AM (9), centage of beads that had three or more phagocytes attached initial experiments in this study were performed with was determined by screening 200 beads. Rosetting of phago- freshly isolated clinical strains. The kinetics of phago-

Macrophage Cytophilic IgG-mediated Phagocytosis 65 cytosis of four such S. aureus strains by PMN, MN, cocci, we next studied the phagocytosis of 10 strains and AM is given in Fig. 1. Phagocytosis was deter- with known differences in cell wall composition. mined after 5-, 15-, and 60-min incubation, and op- Strains included S. aureus 502A, Cowan I (a protein sonized as well as nonopsonized staphylococci were A "rich" strain), EMS, and Wood 46 (both protein A used. Opsonized bacteria were recognized and readily "poor"), a related pair of strains, one of which was taken up by all three types of phagocytic cells with coagulase- and clumping factor-negative, another pair 40-60% of the staphylococci being phagocytized after of strains (HSmR and 52A5) one of which was deficient 5-min incubation. in cell wall teichoic acid (52A5), and two clinical iso- The capacity of AM to phagocytize S. aureus in the lates of S. epidermidis (protein A "negative"). absence of opsonins was confirmed with three of the After 60-min incubation the mean (range) percent four clinical isolates. Although the rate of uptake of phagocytosis of the 10 strains was 6 (1-20)% by PMN, these three nonopsonized bacteria was slower than that 13 (3-29)% by MN, and 46 (8-87)% by AM (Fig. 2). of opsonized bacteria, 75-80% were AM-associated AM uptake of staphylococci was good (72-87%) with after 60-min incubation. One strain was not well rec- four strains, intermediate (31-48%) with two strains, ognized by AM in the absence of opsonins (30% uptake and poor (8-13%) with the remaining four strains. AM after 60 min, Fig. 1). In contrast to AM, PMN, and from smokers and nonsmokers gave very similar results MN phagocytosis of nonopsonized S. aureus was <5 as did AM from male and female donors (data not and 20%, respectively (Fig. 1). MN were somewhat shown). The strains that were well phagocytized by better than PMN in recognizing nonopsonized staph- AM were 502A, Cowan I, and the coagulase-positive ylococci, and, interestingly, MN showed the poorest and -negative pair of S. aureus strains. Poor uptake uptake of the one strain that was also relatively poorly was observed with both strains of S. epidermidis, and taken up by AM (Fig. 1). Nonopsonized E. coli ON2 with protein A-deficient S. aureus Wood 46 and EMS was not phagocytized by PMN, MN, and AM (uptake strains. The teichoic acid-deficient 52A5 strain and its .3%, data not shown). Unless specifically stated, fur- parent strain HSmR showed intermediate phagocytosis ther data is presented for nonopsonized staphylococci by AM. Collectively, the data suggested that AM rec- only. ognition of nonopsonized staphylococci may depend Phagocytosis of laboratory strains of S. aureus and on the presence of cell wall protein A, and that teichoic clinical isolates of S. epidermidis. To determine the acid, clumping factor, and coagulase production were recognition site for AM in the cell wall of staphylo- not greatly involved.

100 PUN MN

80

Jx60 / 1-0 ~40

5 15 60 5 15 60 5 15 60 Minutes FIGURE 1 Phagocytosis of four fresh clinical isolates of S. aureus by PMN, MN, and AM. The percent uptake of opsonized (closed symbols) and nonopsonized (open symbols) bacteria by phagocytic cells was determined after 5, 15, and 60 min of incubation. The bacteria to phagocyte ratio was 10:1. Opsonized and nonopsonized staphylococci were obtained by incubation (30 min at 37°C) in 10% normal pooled human serum and GHBSS, respectively, before adding to the phagocytes.

66 Verbrugh, Hoidal, Nguyen, Verhoef, Quie, and Peterson Although MN uptake of staphylococci was much less efficient (Figs. 1 and 2), the rank order of uptake of the strains closely paralleled the order of phagocytosis found with AM. Thus, strains that were well recog- @:80 * nized by AM were also phagocytized to some extent by MN, and strains not well recognized by AM were 0~~~~~~~~0 likewise poorly taken up by MN. When the data for uptake of laboratory and clinical strains (n = 14) were 60 subjected to linear regression analysis, the uptake by 260 AM and MN correlated very well. (slope b = 3.6, cor- relation coefficient r = 0.86, P < 0.001). n40 - Role of protein A in phagocytosis of staphylococci. To further define the potential role of protein A, the amount of protein A on available the surface of a total 20 0 of 22 strains of staphylococci was determined. Five strains (three S. epidermidis, S. aureus M, and EMS) had undetectable cell surface protein A (<10 pg/106 at'*|/ '..i A cocci). Protein content of the remaining strains (all .C10 100 1000 10,000 S. aureus) varied from 140-6,000 pg/106 cocci. AM unde - phagocytosis was <6% for the five protein A-negative tectable strains, and was found to directly correlate with the Protein A Content (pg/10 6 cocci) amount of surface protein A for the 17 protein A-pos- itive S. aureus strains (Fig. 3). Trypsinization of four FIGURE 3 Correlation between cell wall protein A content protein A-rich strains (protein A content 2 5,000 of 22 strains of staphylococci and their nonopsonic phago- pg/ cytosis by AM. The protein A content of the strains was 106 cocci) removed 80-90% of their surface protein A, determined by passive hemagglutination of sensitized SRBC. and their uptake by AM decreased accordingly from Phagocytosis was determined as in the legend of Fig. 2. r, >75% to <24% (data not presented in Fig. 3). correlation coefficient. AM rosetting around Sepharose. Because the above results argued for protein A as the recognition Therefore, the ability of PMN, MN, and AM to rosette site for AM, we next tested the hypothesis that AM around protein A-coated beads by Sepharose CL-4B would recognize other protein A-bearing surfaces. was evaluated. AM avidly rosetted around protein A-coated Se- 100 PMN MN AM pharose, but not around Sepharose without protein A (Fig. 4). Rosetting of MN around protein A-Sepharose occurred much less frequently, and was virtually ab- I 80 V sent with PMN (Fig. 4) and neither cell rosetted around Sepharose without protein A (not shown in Fig. 011Cacn 4): The percentage of protein A-coated beads that had three or more phagocytes attached was <6% for PMN, 60 F 25-35% for MN, and >90% for AM. In addition, beads 0 coE positive for AM rosettes regularly had >10 AM at- 0 0 tached and AM-induced "bridging", i.e., agglutina- co0 tion, of beads occurred 40 F 0 (Fig. 4). Such bridging was 00. never observed with MN or PMN, and rosette-positive o- beads always had fewer than six cells attached to them. * 0 Metabolic responses of AM. The uptake of non- 20 _ I opsonized staphylococci by AM was accompanied by an increase in the rate of conversion of [1-_4C]glucose -3 1 to 14CO2 and in the release of °2 by AM (Table I). - Incubation of AM with a strain rich in protein A -* ; (Cowan FIGURE 2 Phagocytosis of nonopsonized laboratory strains I, 5,000 pg protein A/106 cocci) induced a of S. aureus (n = 8) and fresh clinical isolates of S. epider- fourfold rise in glucose oxidation and a twofold rise midis (n = 2) by PMN, MN, and AM. The percent uptake in the amount of O2 released. In contrast, the protein of bacteria by phagocytic cells was determined after 60-min A-negative mutant strain EMS did not induce an in- incubation. The bacteria to phagocyte ratio was 10:1. crease in superoxide release, and only a twofold rise

Macrophage Cytophilic IgG-mediated Phagocytosis 67 C

a

9 C 4 U

*,::. :.:

;:*::

.1 do It >}:

.: :e :: ::

.: ..

M

:. ::: . ARmeS : ..

...... eV.:4f.-. .: 4...~4 00~~

. 8 I 4 1*~~~~~~~

0

FIGURE 4 Rosetting of PMN (upper plate) and AM (lower plate) around Sepharose CL-4B with covalently linked protein A. Note positive rosettes with AM, but no rosetting of PMN. X125-160. in the rate of glucose oxidation was observed (Table ized staphylococci, and protein A is known to bind I). No significant differences were observed when live nonspecifically to immunoglobulins (21), purified and heat-killed (30 min, 70°C) bacteria were com- preparations of PMN, MN, and AM were studied for pared (data not shown). the presence of surface-immunoglobulins by immu- Detection of surface immunoglobulins on AM. nofluorescence microscopy. Since these experiments indicated that protein A was AM showed relatively intense fluorescence when the bacterial ligand for AM phagocytosis of nonopson- stained with polyvalent or y-chain specific antisera

68 Verbrugh, Hoidal, Nguyen, Verhoef, Quie, and Peterson TABLE I Metabolic Responses of AM to Challenge with Nonopsonized S. aureus

AM metabolic activityt

Hexose monophosphate AM challenge' shunt O° production

cpm/20 min/5 X 0I cells nM/20 min/5 X 10' cells None ("resting" AM) 1,811±147§ 7.1±0.1 S. aureus EMS 3,931±318 6.3±0.2 S. aureus Cowan I 9,475±372 14.1±0.8

AM were incubated (20 min at 37°C) with strain EMS (protein A-negative) or strain Cowan I (protein A-positive) at a final bacteria to macrophage ratio of 50:1. t Hexose monophosphate shunt activity was assessed by the release of 4C02 from [1- 14C] glucose, and O2 production by the reduction of extracellular ferricytochrome c; see Methods. § Results are expressed as means±SE of four separate experiments. and with FITC-protein A, but were negative with a- demonstrate that, in contrast to blood PMN and MN, or ,u-chain specific conjugates (Fig. 5). AM from smok- AM carry appreciable amounts of membrane-bound ers and nonsmokers were found to have surface IgG. IgG that may be involved in protein A-mediated up- In addition to surface IgG, smoker AM also contained take of staphylococci. variable amounts of yellow autofluorescent material Inhibition of AM phagocytosis. Treatment of AM that seemed to be localized within cytoplasmic gran- with trypsin or pronase for 30 min had little effect on ules or vacuoles. Smoker AM autofluorescence has been the ability of AM to phagocytize nonopsonized S. au- reported before (22). MN were weakly positive for reus Cowan I, but greatly inhibited the uptake of op- surface IgG, and PMN did not show any fluorescence sonized bacteria (Table II). Neuraminidase (30 min) with the antisera used (data not shown). These findings had little or no effect on the uptake of either opsonized

FIGURE 5 Plasma membrane-associated IgG on AM of a nonsmoker. Note uniform surface fluorescence and size of nonsmoker AM.

Macrophage Cytophilic IgG-mediated Phagocytosis 69 or nonopsonized staphylococci. It was additionally Nature of AM surface IgG. The AM surface IgG found that treatment of AM with trypsin, pronase, or was of a different nature than the IgG found on the papain for 30 min did not result in extensive loss of surface of PMN pretreated with agg-IgG. The agg- AM surface IgG; focal loss of the dense fluorescent IgG-treated PMN had a granular, speckled appearance "coat" of some AM was noted, resulting in a "stippled" when stained with FITC-protein A unlike the diffuse appearance of these cells (data not shown). However, and uniform staining of the AM surface shown in Fig. when incubation of AM with each of these three en- 5. Also, when PMN with attached agg-IgG were in- zymes was extended to 2 h, virtually all surface IgG cubated at 37°C they cleared all their surface IgG was removed. within 2 h, in contrast to AM that retained their surface Opsonization of protein A-rich strains with 10% nor- IgG over this period of incubation (Table IV). Fur- mal serum greatly reduced their ability to agglutinate thermore, agg-IgG-treated PMN remained unable to sensitized SRBC. The agglutination titers of four pro- phagocytize nonopsonized S. aureus Cowan I (Table tein A-rich strains, including S. aureus Cowan I, were IV). PMN incubated with concentrated lung lavage decreased by 84-97% after opsonization in 10% serum. fluid (containing 1 mg IgG/ml) did not become pos- Taken together, these findings indicate that opsoni- itive for surface immunoglobulins by immunofluores- zation of S. aureus masks cell surface protein A resi- cence and, as with agg-IgG treatment, remained un- dues, and that these bacteria are taken up by AM via able to phagocytize nonopsonized S. aureus Cowan I a trypsin- and pronase-sensitive receptor mechanism. (Table IV). The uptake of nonopsonized S. aureus, however, de- Taken together, these results indicate that normal pends on protein A and is mediated through trypsin- human lung lavage fluids do not contain appreciable and pronase-insensitive receptors of AM, and may in- quantities of aggregated or immune-complexed IgG, volve surface IgG. and that the surface IgG on AM is also not aggregated To further define the role of surface IgG in phago- or immune-complexed. cytosis, AM were pretreated with soluble purified pro- Phagocytosis by human peritoneal macrophages tein A or with F(ab')2 fragments specific for the Fc and by AM from different animal species. In four part of IgG (anti-Fc). The uptake of opsonized S. au- separate experiments, human peritoneal macrophages reus Cowan I was little affected by protein A or anti- phagocytized 59±4.9% (mean±SE) of nonopsonized S. Fc treatment of AM, but the uptake of nonopsonized aureus Cowan I after 60-min incubation. In contrast, staphylococci was inhibited (Table III). This obser- only 13±0.7% of the protein A-deficient EMS strain vation lends further support to the hypothesis that op- was taken up. Also, peritoneal macrophages stained sonized and nonopsonized S. aureus are phagocytized positively with FITC-protein A as was found with AM. via distinct AM receptor mechanisms, and that the Thus, human peritoneal macrophages also appear to receptor for nonopsonized staphylococci is AM possess cytophilic IgG, which can mediate phagocy- surface IgG. tosis of protein A containing S. aureus.

TABLE II Inhibition of S. aureus Cowan I Phagocytosis by Protease and Neuraminidase Treatment of AM

Inhibition of phagocytosist of

Nonopsonized Number AM treatment' Opsonized bacteria bacteria of tests

Trypsin, 0.1 mg/ml 46.3±4.1 8.0±2.6 3 1.0 mg/ml 57.5±5.3 17.5±1.8 2 Pronase, 1.0 mg/ml 86.7±1.3 7.7±3.0 3 Neuraminidase, 0.1 U/ml 18.5±1.3 -0.3±6.5 3 e AM were incubated (30 min at 37°C) with indicated , washed, and mixed with either opsonized (10% serum) or nonopsonized staphylococci. t The initial rate of phagocytosis was determined (percent uptake at 5 min) and these data were used to calculate mean±SE percent inhibition compared with simultaneously run HBSS-treated AM.

70 Verbrugh, Hoidal, Nguyen, Verhoef, Quie, and Peterson TABLE III Inhibition of S. aureus Cowan I Phagocytosis by Protein A and Anti-Fc Treatment of AM

Inhibition of phagocytosist of Number AM treatment' Opsonized bacteria Nonopsonized bacteria of tests

Protein A, 1 mg/ml 9.0±2.6 52.7±1.0 3 Anti-Fc, 1 mg/ml 16.0±6.5 57.5±2.3 4 AM were incubated with protein A or goat F(ab)2 against human IgG Fc (anti-Fc) for 30 min at 37°C, washed, and mixed with either opsonized or nonopsonized staph- ylococci. I The initial rate of phagocytosis was determined (percent uptake at 5 min) and these data were used to calculate the mean±SE percent inhibition of phagocytosis compared with simultaneously run HBSS-treated AM.

Because phagocytosis of staphylococci by AM has DISCUSSION been studied in vitro and in vivo in other animal spe- cies, phagocytosis by AM from humans, rabbits, rats, The main goal of this investigation was to elucidate and hamsters was compared. In six separate experi- the mechanism of phagocytosis of nonopsonized staph- ments, the mean (range) percent uptake of nonopson- ylococci by human AM. We found that phagocytosis ized S. aureus Cowan I was 80 (65-88)% for human of nonopsonized staphylococci by these phagocytes AM, 18 (10-30)% for rabbit AM, 11 (7-14)% for rat only occurs with protein A-positive strains, and that AM, and 26 (17-34)% for hamster AM. In comparison the efficiency of uptake depends on the amount of with Cowan I, the uptake of the protein A-negative protein A on the bacterial surface. mutant strain EMS was strikingly lower for human AM A likely explanation for the protein A receptor (11 [5-141%), but was also significantly lower for AM mechanism of human AM was found by demonstrating of the other animal species. the presence of surface IgG antibodies on these cells.

TABLE IV Differences between AM Surface IgG and agg-IgG Bound to PMN

Reactivity with FITC-protein A after 37'C incubation forl Phagocytosis of nonopsonized S. Phagocyte Pretreatment' 1 min 60 min 120 min aureus§

AM GHBSS + + + 75±0.7 (diffuse) PMN GHBSS - ND ND 11±3.1 Lung fluid - ND ND 13±2.6 agg-IgG + + - 15±0.7 (speckled) 'AM and PMN (5 X 106/ml GHBSS) were incubated (150 min at 4°C) with medium alone (GHBSS), concentrated lung lavage fluid diluted 1:2 in GHBSS, or 1 mg agg-IgG/ ml GHBSS, then washed twice and used. t Washed, pretreated cells were incubated in GHBSS at 37°C for indicated times and then stained for surface IgG with FITC-protein A as described in Methods. Positive, +; trace, ±; absent, -. ND, not determined. § Washed, pretreated cells were incubated with nonopsonized S. aureus Cowan I for 60 min and the present uptake was determined. Results are mean±SE of three separate experiments.

Macrophage Cytophilic IgG-mediated Phagocytosis 71 Although macrophage surface antibodies have been (40-42). Protein A, on the other hand, has been found found in a number of animal species (23-26), little to bind at a locus between the CH2 and CH3 domains attention has been focused on the presence and role and does not interfere with the capacity of the Fc of surface antibodies on human phagocytic cells. Small fragment to bind to Fc receptors (CH3 domain) or to quantities of IgG, not detectable with fluorescent an- the first component of complement (CH2 domain) (43- tibody techniques, have been demonstrated on human 45). Interestingly, injury to human platelets by S. au- PMN and MN by autoradiography (27). In addition, reus has recently been shown also to involve interac- human breast-milk macrophages obtained in the early tions of cell wall protein A, IgG, and platelet Fc re- postpartum period have been shown to contain ap- ceptors (46). preciable quantities of IgA and IgM, but no detectable The observed increases in AM hexose monophos- IgG (28). We now report that human AM have surface phate shunt activity and superoxide anion production IgG antibodies in quantities that permit ready detec- induced by nonopsonized S. aureus do not differ sig- tion by immunofluorescence microscopy. The well nificantly from previously reported AM responses to known binding of protein A to certain subclasses of opsonized staphylococci (16, 17). Although it is not human IgG (21, 29) would infer that the observed known how these responses are triggered, the binding phagocytosis of nonopsonized staphylococci is the con- of protein A to IgG has been shown to result in sig- sequence of the interaction between bacterial cell wall nificant conformational changes in the Fc fragment, protein A and surface IgG molecules of AM. which may provide the initial stimulus for the meta- The AM surface IgG and uptake of nonopsonized bolic burst (47). staphylococci were resistant to short (30 min) treat- Our experiments indicated that the AM surface IgG ments with several proteolytic enzymes. Although are not in an aggregated or immune-complexed state. serum IgG is more sensitive to these enzymes than The uniform and diffuse staining of the AM surface, secretory IgA, even serum IgG would not be expected the persistence of the AM surface IgG upon prolonged to become extensively degraded by these relatively incubation at 37°C, and the ability of the surface IgG mild proteolytic conditions (30, 31). Longer incubation to mediate ingestion of bacteria contrast with our re- times (22 h) of AM with the same proteases, however, sults and those of other investigators (48-51) that have did remove most of the AM surface IgG. In contrast, studied the interactions between aggregated or im- the AM receptor for opsonized staphylococci was de- mune-complexed antibodies with phagocytic cells. graded by a 30-min exposure to proteases. This sug- The IgG found on normal human AM more likely fits gests that C3 receptors of AM are involved in the rec- the category of so called cytophilic immunoglobulins ognition of opsonized but not of nonopsonized (52, 39). staphylococci, since receptors for C3 are known to be The role in host defense of cytophilic antibodies on trypsin sensitive (32-35). human AM, and on its precursor cell, the circulating In this study we did not determine the subclass(es) MN (53), is currently completely unknown. Smoker of IgG that are present on human AM, and no data AM were found to contain large amounts of autoflu- is available on the subclass specificities of the IgG re- orescent cytoplasmic inclusions as has been noted by ceptor of AM. PMN, and MN, however, have been others (22), and one possibility might be that these found to bind monomeric and immune-complexed inclusions represent antigenic material that has been IgG, and IgG3 antibodies (36-38); less binding has been cleared via specific cytophilic antibody. Previous stud- observed with IgG4 or IgA, and IgG2, IgM, IgD, and ies suggested that protein A inhibits opsonization for IgE are not cytophilic for PMN and MN (37). Since phagocytosis by PMN (54, 55). Paradoxically, protein protein A has its greatest affinity for IgG1 and IgG2, A was found in this study to promote phagocytosis of and does not bind to IgG3, one could speculate that nonopsonized staphylococci by human AM, and this human AM surface antibody is primarily of the IgG, may be important in local immunity of the human subclass. lung. Also, some strains of group A and the majority The binding of protein A to surface-bound IgG raises of strains of group C and G streptococci carry an Fc the question of the molecular orientation of the IgG binding structure analogous to protein A (56). These molecules on the AM surface. Binding of cytophilic strains may thus also be phagocytized via cyto- antibodies to macrophages, PMN, and MN have been philic IgG. demonstrated to involve the Fc region of the antibody Our findings with human peritoneal macrophages, molecule (25, 37, 39). Protein A has also been shown although obtained from patients, suggest that cyto- to bind to the Fc portion of IgG (21, 29). However, philic IgG-mediated phagocytosis may be a charac- different domains of the Fc fragment may be involved. teristic that is common to human tissue macrophages. The interaction with Fc receptors of PMN or MN prob- The inefficiency of AM from rabbits, rats, and ham- ably involves the Fc CH3 domain of the IgG molecule sters to phagocytize nonopsonized staphylococci is in

72 Verbrugh, Hoidal, Nguyen, Verhoef, Quie, and Peterson agreement with previous work using these animal spe- opsonization and serum complement activation by en- cies (57-60). These differences out capsulated staphylococci. Infect. Immun. 20: 770-775. species' point that 12. McLean, R. H., A. Forsgren, B. Bjorksten, Y. Kim, functions of human macrophages cannot be directly P. G. Quie, and A. F. Michael. Decreased serum factor inferred from studies using macrophages from other B concentration associated with decreased opsonization animals. of Escherichia coli in the idiopathic nephrotic syndrome. Pediatr. Res. 11: 910-916. 13. B6yum, A. 1967. Isolation of mononuclear cells and ACKNOWLEDGMENTS granulocytes from human blood. Isolation of mononu- clear cells by one centrifugation and of granulocytes by We wish to thank Dr. Youngki Kim and Dr. F. G. Cosio for combining centrifugation and sedimentation of 1 g. their advice and suggestions, and Dr. William Korchik for Scand. J. Clin. Lab. Invest. 21(Suppl 97): 77-89. his help in obtaining peritoneal dialysate fluids. 14. Ackerman, S. K., and S. D. Douglas. 1978. Purification This investigation was supported, in part, by U. S. Public of human monocytes on microexudate coated surfaces. Health Service research grants AI-08821-10 and AI-06931- J. Immunol. 120: 1372-1374. 15 from the National Institute of Allergy and Infectious 15. Hoidal, J. R., J. G. White, and J. E. Repine. 1979. In- Diseases and by funds from the Minnesota Thoracic Society. fluence of cationic local anesthetics on the metabolism Dr. Verbrugh is a Postdoctoral International Research Fel- and ultrastructure of human alveolar macrophages. J. low supported by the John E. Fogarty International Center Lab. Clin. Med. 93: 857-863. grant FOS-TW02952-01. 16. Hoidal, J. R., G. D. Beall, F. L. Rasp, Jr., B. Holmes, J. G. White, and J. E. Repine. 1978. Comparison of the REFERENCES metabolism of alveolar macrophages from humans, rats, and rabbits. J. Lab. Clin. Med. 92: 787-794. 1. Verhoef, J., P. K. Peterson, Y. Kim, L. D. Sabath, and 17. Hoidal, J. R., J. E. Repine, G. D. Beall, F. L. Rasp, Jr., P. G. Quie. 1977. Opsonic requirements for staphylo- and J. G. White. 1978. The effect of phorbol myristate coccal phagocytosis: heterogeneity among strains. Im- acetate on the metabolism and ultrastructure of human munology. 33: 191-197. alveolar macrophages. Am. J. Pathol. 91: 469-483. 2. Peterson, P. K., J. Verhoef, D. Schmeling, and P. G. 18. Winblad, S., and C. Ericson. 1973. Sensitized sheep red Quie. 1977. Kinetics of phagocytosis and bacterial killing cells as a reactant for Staphylococcus aureus protein A. by human polymorphonuclear leukocytes and mono- Acta Pathol. Microbiol. Scand. Sect. B Microbiol. 81: cytes. J. Infect. Dis. 136: 502-508. 150-156. 3. Quie, P. G., R. P. Messner, and R. C. Williams, Jr. 1968. 19. Gajl-Peczalska, K. J., J. A. Hansen, C. D. Bloomfield, Phagocytosis in subacute bacterial endocarditis: local- and R. A. Good. 1973. B Lymphocytes in untreated pa- ization of the primary opsonic site to Fc fragment. J. tients with malignant lymphoma and Hodgkin's disease. Exp. Med. 128: 553-570. J. Clin. Invest. 52: 3064-3073. 4. Wright, A. E., and S. R. Douglas. 1904. An experimental 20. Brown, B. W., Jr., and M. Hollander. 1977. Statistics. A investigation of the role of the body fluids in connection Biomedical Introduction. Wiley-Interscience, Div. of with phagocytosis. Proc. Roy. Soc. (Lond.). 72: 357-370. John Wiley & Sons, New York. 261-307. 5. Li, I. W., and S. Mudd. 1965. The heat-labile serum 21. Forsgren, A., and J. Sjoquist. 1966. Protein A from S. factor associated with intracellular killing of Staphylo- aureus. I. Pseudoimmune reaction with human gam- coccus aureus. J. Immunol. 94: 852-857. maglobulin. J. Immunol. 97: 822-827. 6. Humphreys, D. W., L. J. Wheat, and A. White. 1974. 22. Martin, R. R. 1973. Altered morphology and increased Staphylococcal heat-stable opsonins. J. Lab. Clin. Med. acid hydrolase content of pulmonary macrophages from 84: 122-128. cigarette smokers. Am. Rev. Respir. Dis. 107: 596-601. 7. Peterson, P. K., B. J. Wilkinson, Y. Kim, D. Schmeling, 23. Boyden, S. V. 1964. Cytophilic antibody in guinea pigs S. D. Douglas, P. G. Quie, and J. Verhoef. 1978. The key with delayed-type hypersensitivity. Immunology. 7:474- role of peptidoglycan in the opsonization of Staphylo- 483. coccus aureus. J. Clin. Invest. 61: 597-609. 24. Tizard, I. R. 1969. Macrophage cytophilic antibody in 8. Verbrugh, H. A., W. C. Van Dijk, M. E. Van Erne, R. mice. Differentiation between adherence due Peters, P. K. Peterson, and J. Verhoef. 1980. Opsonic to these antibodies and opsonic adherence. Int. Arch. recognition of staphylococci mediated by cell wall pep- Allergy Appl. Immunol. 36: 332-346. tidoglycan: antibody-independent activation of human 25. Tizard, I. R. 1971. Macrophage-cytophilic antibodies complement and opsonic activity of peptidoglycan an- and the functions of macrophage-bound immunoglob- tibodies. J. Immunol. 124: 1167-1173. ulins. Bacteriol. Rev. 35: 365-378. 9. Hoidal, J. R., D. Schmeling, and P. K. Peterson. 1981. 26. Green, R. J., and J. P. Kreier. 1978. Demonstration of Phagocytosis, bacterial killing, and metabolism by pu- the role of cytophilic antibody in resistance to malaria rified human polymorphonuclear leukocytes, mono- parasites (Plasmodium berghei) in rats. Infect. Immun. cytes, and pulmonary alveolar macrophages. J. Infect. 19: 138-145. Dis. 144: 61-71. 27. Ishizaka, K., H. Tomioka, and T. Ishizaka. 1970. Mech- 10. Hof, D. G., J. E. Repine, P. K. Peterson, and J. R. Hoidal. anisms of passive sensitization. I. Presence of IgE and 1980. Phagocytosis by human alveolar macrophages and IgG molecules on human leukocytes. J. Immunol. 105: neutrophils: qualitative differences in the opsonic re- 1459-1467. quirements for uptake of Staphylococcus aureus and 28. Pittard, W. B., III, S. H. Polmar, and A. A. Fanaroff. Streptococcus pneumoniae in vitro. Am. Rev. Respir. 1977. The breast milk macrophage: a potential vehicle Dis. 121: 65-71. for immunoglobulin transport. J. Reticuloendothel. Soc. 11. Peterson, P. K., Y. Kim, B. J. Wilkinson, D. Schmeling, 22: 597-603. A. F. Michael, and P. G. Quie. 1978. Dichotomy between 29. Kronvall, G., and R. C. Williams, Jr. 1969. Differences

Macrophage Cytophilic IgG-mediated Phagocytosis 73 in anti-protein A activity among IgG sub-groups. J. Im- meric IgG to Fc receptor-bearing cells. Immunology. 38: munol. 103: 828-833. 173-179. 30. Brown, W. R., R. W. Newcomb, and K. Ishizaka. 1970. 46. Hawiger, J., S. Steckley, D. Hammond, C. Cheng, S. Proteolytic degradation of exocrine and serum immu- Timmons, A. D. Glick, and R. M. Des Pres. 1979. Staph- noglobulins. J. Clin. Invest. 49: 1374-1380. ylococci-induced human platelet injury mediated by 31. Underdown, B. J., and K. J. Dorrington. 1974. Studies protein A and immunoglobulin G Fc fragment receptor. on the structural and conformational basis for the rel- J. Clin. Invest. 64: 931-937. ative resistance of serum and secretory immunoglobulin 47. Langone, J. J., M. D. P. Boyle, and T. Borsos. 1978. A to proteolysis. J. Immunol. 112: 949-959. Studies on the interaction between protein A and im- 32. Lay, W. H., and V. Nussenzweig. 1968. Receptors for munoglobulin G. I. Effect of protein A on the functional complement on leukocytes. J. Exp. Med. 128: 991-1007. activity of IgG. J. Immunol. 121: 327-331. 33. Griffin, F. M., C. Bianco, and S. C. Silverstein. 1975. 48. Starkebaum, G., and W. P. Arend. 1979. Neutrophil- Characterization of the macrophage receptor for com- binding immunoglobulin G in systemic lupus erythem- plement and demonstration of its functional indepen- atosus. J. Clin. Invest. 64: 902-912. dence from the receptor for the Fc portion of immu- 49. Knutson, D. W., A. Kylstra, and L. E. Van Es. 1977. noglobulin G. J. Exp. Med. 141: 1269-1277. Association and dissociation of aggregated IgG from rat 34. Verhoef, J., P. K. Peterson, and P. G. Quie. 1977. Human peritoneal macrophages. J. Exp. Med. 145: 1368-1381. polymorphonuclear receptors for staphylococcal opso- 50. Leslie, R. G. Q. 1980. Macrophage handling of soluble nins. Immunology. 33: 231-239. immunocomplexes. Ingestion and digestion of surface- 35. Shurin, S. S., and T. P. Stossel. 1978. Complement (C3)- bound complexes at 4, 20, and 37°C. Eur. J. Immunol. mediated phagocytosis by lung macrophages. J. Im- 10: 323-333. munol. 120: 1305-1312. 51. Alexander, E. L., J. A. Titus, and D. M. Segal. 1979. 36. Huber, H., S. D. Douglas, J. Nusbacher, S. Kochwa, and Human leukocyte Fc (IgG) receptors: quantitation and R. E. Rosenfield. 1971. IgG subclass specificity of human affinity with radiolabeled affinity cross-linked rabbit monocyte receptor sites. Nature (Lond.). 229: 419-420. IgG. J. Immunol. 123: 295-302. 37. Lawrence, D. A., W. 0. Weigle, and H. L. Speigelberg. 52. Boyden, S. V., and E. Sorkin. 1960. The adsorption of 1975. Immunoglobulins cytophilic for human lympho- antigen by spleen cells previously treated with antiserum cytes, monocytes, and neutrophils. J. Clin. Invest. 55: in vitro. Immunology. 3: 272-283. 368-376. 53. Hocking, W. G., and D. W. Golde. 1979. The pulmo- 38. Alexander, M. D., J. A. Andrews, R. G. Q. Leslie, and nary-alveolar macrophage (first of two parts). N. Engl. N. J. Wood. 1978. The binding of human and guinea pig J. Med. 301: 586-587. IgG subclasses to homologous macrophage and monocyte 54. Forsgren, A., and P. G. Quie. 1974. Effects of staphy- Fc receptors. Immunology. 35: 119-144. lococcal protein A on heat-labile opsonins. J. Immunol. 39. Berken, A., and B. Benacerraf. 1966. Properties of an- 112: 1177-1180. tibodies cytophilic for macrophages. J. Exp. Med. 123: 55. Peterson, P. K., J. Verhoef, L. D. Sabath, and P. G. Quie. 119-144. 1977. Effect of protein A on staphylococcal opsonization 40. Ciccimarra, F., F. S. Rosen, and E. Merler. 1975. Lo- Infect. Immun. 17: 475-482. calization of the IgG effector site for monocyte recep- 56. Myhre, E. B., and G. Kronvall. 1977. Heterogeneity of tors. Proc. Natl. Acad. Sci. U. S. A. 72: 2081-2086. nonimmune immunoglobulin Fc reactivity among gram- 41. Yasmeen, D., J. R. Ellison, K. J. Dorrington, and R. H. positive cocci: description of three major types of re- Painter. 1973. Evidence for the domain hypothesis: lo- human G. Immun. cation of the site of cytophilic activity toward guinea ceptors for immunoglobulin Infect. pig macrophages in the CH3 homology region of human 17: 475-482. immunoglobulin G. J. Immunol. 110: 1706-1709. 57. LaForce, F. M. 1976. Effect of alveolar lining material 42. Okator, G. P., M. W. Turner, and F. C. Hay. 1974. Lo- on phagocytic and bactericidal activity of lung macro- calization of monocyte binding site of human immu- phages against S. aureus. J. Lab. Clin. Med. 88: 691- noglobulin G. Nature (Lond.). 248: 228-230. 699. 43. Lancet, D., D. Isenman, J. Sjodahl, J. Sjoquist, and I. 58. Juers, J. A., R. M. Rogers, J. B. McCurdy, and W. W. Pecht. 1978. Interactions between staphylococcal pro- Cook. 1976. Enhancement of bactericidal capacity of tein A and immunoglobulin domains. Biochem. Biophys. alveolar macrophages by human alveolar lining mate- Res. Commun. 85: 608-614. rial. J. Clin. Invest. 58: 271-275. 44. Deisenhofer, J., T. A. Jones, R. Huber, J. Sjbdahl, and 59. LaForce, F. M., W. J. Kelly, and G. L. Huber. 1973. J. Sjoquist. 1978. Crystallization, crystal structure anal- Inactivation of staphylococci by alveolar macrophages ysis, and atomic model of the complex formed by a hu- with preliminary observations on the importance of al- man Fc fragment and fragment B of protein A from veolar lining material. Am. Rev. Respir. Dis. 108: 784- Staphylococcus aureus. Hoppe-Seyler's Z. Physiol. Chem. 790. 359: 975-985. 60. Murphy, S. A., R. K. Root, and A. D. Schreiber. 1979. 45. Sulica, A., C. Medeaan, M. Laky, D. Onica, J. Sj6quist, The role of antibody and complement in phagocytosis and V. Ghetie. 1979. Effect of protein A of Staphylo- by rabbit alveolar macrophages. J. Infect. Dis. 140: 896- coccus aureus on the binding of monomeric and poly- 903.

74 Verbrugh, Hoidal, Nguyen, Verhoef, Quie, and Peterson